ClinConnect ClinConnect Logo
Search / Trial NCT03225144

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Launched by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) · Jul 20, 2017

Trial Information

Current as of May 29, 2025

Recruiting

Keywords

Tdp 43 Progressive Supranuclear Palsy Motor Neuron Disease Frontotemporal Dementia Corticobasal Syndrome Natural History

ClinConnect Summary

This clinical trial is focused on understanding complex neurodegenerative disorders, particularly those related to conditions like Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). Researchers are investigating whether these disorders share similar causes or risk factors, especially those related to certain proteins that can build up in brain cells. The goal is to evaluate individuals who have issues with movement or thinking to see if they can participate in further studies that may help us learn more about these diseases.

If you're an adult aged 18 or older and have been diagnosed with FTD, ALS, or related disorders, you might be eligible to participate. The process involves several tests and assessments over a few days, including checking your medical history, performing movement and memory tests, and taking blood samples. Some tests might involve imaging techniques like MRI, which takes pictures of your brain and body. Participation in this study could help researchers find better ways to understand and treat these challenging conditions, and even if you’re not eligible, you may still be contacted for future research opportunities.

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • Patients will be included if they
  • Are age 18 or older
  • Have been given a diagnosis by a neurologist of frontotemporal dementia, primary progressive aphasia, semantic dementia, motor neuron disorder, amyotrophic lateral sclerosis, progressive bulbar palsy, corticobasal neurodegenerative disorder OR
  • Carry a mutation in a gene that causes familial ALS or FTD
  • EXCLUSION CRITERIA:
  • Patients will be excluded if they
  • Have other major neurological or medical diseases that may cause progressive weakness or cognitive dysfunction, such as structural brain or spinal cord disease, metabolic diseases, paraneoplastic syndromes, infectious diseases, peripheral neuropathy or radiculopathy or other significant neurological abnormalities.
  • Have an unstable medical condition that, in the opinion of the investigators, makes participation unsafe
  • Require daytime ventilator support at the time of study entry
  • Are unable to travel to NIH
  • Patients with pacemakers or other implanted electrical devices, brain stimulators, dental implants, aneurysm clips (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and cochlear implants), permanent eyeliner, implanted delivery pumps, or shrapnel fragments, metal fragments in the eye) will not be excluded but will not undergo magnetic resonance imaging.
  • Patients with tattoos above the neck or permanent make up will be excluded from undergoing 7T MRI.

About National Institute Of Neurological Disorders And Stroke (Ninds)

The National Institute of Neurological Disorders and Stroke (NINDS) is a leading component of the National Institutes of Health (NIH), dedicated to advancing our understanding of the brain and nervous system through innovative research. NINDS sponsors and conducts clinical trials aimed at developing effective treatments and improving patient outcomes for a wide range of neurological disorders, including stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. By fostering collaboration among researchers, healthcare providers, and patient communities, NINDS plays a pivotal role in transforming scientific discoveries into clinical applications, ultimately enhancing the quality of life for individuals affected by neurological conditions.

Locations

Bethesda, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Justin Y Kwan, M.D.

Principal Investigator

National Institute of Neurological Disorders and Stroke (NINDS)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials